Follow
Avyakta Kallam, MD, FACP
Avyakta Kallam, MD, FACP
University of Nebraska Medical Center
No verified email
Title
Cited by
Cited by
Year
Thrombotic thrombocytopenia after Ad26. COV2. S vaccination
KL Muir, A Kallam, SA Koepsell, K Gundabolu
New England Journal of Medicine 384 (20), 1964-1965, 2021
4422021
NCCN guidelines insights: hematopoietic growth factors, version 1.2020: featured updates to the NCCN guidelines
PS Becker, EA Griffiths, LM Alwan, K Bachiashvili, A Brown, R Cool, ...
Journal of the National Comprehensive Cancer Network 18 (1), 12-22, 2020
862020
T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology
SM Horwitz, S Ansell, WZ Ai, J Barnes, SK Barta, J Brammer, ...
Journal of the National Comprehensive Cancer Network 20 (3), 285-308, 2022
652022
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ...
Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022
622022
Clear cell renal carcinoma
SA Padala, A Kallam
StatPearls [Internet], 2023
482023
Considerations for use of hematopoietic growth factors in patients with cancer related to the COVID-19 pandemic
EA Griffiths, LM Alwan, K Bachiashvili, A Brown, R Cool, P Curtin, ...
Journal of the National Comprehensive Cancer Network 19 (13), 18-21, 2020
462020
Zilovertamab vedotin targeting of ROR1 as therapy for lymphoid cancers
ML Wang, JC Barrientos, RR Furman, M Mei, PM Barr, MY Choi, S de Vos, ...
NEJM evidence 1 (1), EVIDoa2100001, 2022
442022
HPV status and survival in non-oropharyngeal squamous cell carcinoma of the head and neck
VB Wookey, AK Appiah, A Kallam, V Ernani, LM Smith, AK Ganti
Anticancer research 39 (4), 1907-1914, 2019
392019
Diffuse large B cell lymphoma
SA Padala, A Kallam
372020
NCCN Guidelines® insights: hematopoietic growth factors, version 1.2022: featured updates to the NCCN guidelines
EA Griffiths, V Roy, L Alwan, K Bachiashvili, J Baird, R Cool, S Dinner, ...
Journal of the National Comprehensive Cancer Network 20 (5), 436-442, 2022
332022
Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
R Elnair, M Ellithi, A Kallam, V Shostrom, RG Bociek
Annals of hematology 100, 2513-2519, 2021
322021
Recent advances in CAR-T cell therapy for non-Hodgkin lymphoma
A Kallam, JM Vose
Clinical Lymphoma Myeloma and Leukemia 19 (12), 751-757, 2019
312019
Identification and management of lymphedema in patients with breast cancer
P Tandra, A Kallam, J Krishnamurthy
Journal of oncology practice 15 (5), 255-262, 2019
292019
StatPearls
SA Padala, A Kallam
Treasure Island (FL), 2022
282022
VLS-101, a ROR1-targeting antibody-drug conjugate, demonstrates a predictable safety profile and clinical efficacy in patients with heavily pretreated mantle cell lymphoma and …
M Wang, JC Barrientos, RR Furman, M Mei, PM Barr, MY Choi, S de Vos, ...
Blood 136, 13-14, 2020
282020
Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: the effect on resource utilization
A Kallam, K Meyerink, AM Modrykamien
Respiratory Care 58 (3), 431-437, 2013
232013
Proton pump induced thrombocytopenia: A case report and review of literature
A Kallam, A Singla, P Silberstein
Platelets 26 (6), 598-601, 2015
202015
CNS prophylaxis during front-line therapy in aggressive non-Hodgkin lymphomas: real-world outcomes and practice patterns from 19 US academic institutions
VM Orellana-Noia, DR Reed, JM Sen, C Barlow, MK Malecek, BS Kahl, ...
Blood 136, 27-28, 2020
162020
P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY …
M Wang, M Mei, PM Barr, J Barrientos, S de Vos, R Furman, K Patel, ...
HemaSphere 6, 1116-1117, 2022
122022
Undifferentiated embryonal sarcoma of liver
A Kallam, J Krishnamurthy, J Kozel, N Shonka
Rare Tumors 7 (4), 130-132, 2015
122015
The system can't perform the operation now. Try again later.
Articles 1–20